People · Operator
Named in public records as an officer, director or promoter · active 2014–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ralexar Therapeutics, Inc. | — | Pharmaceuticals | Series A | $19.0M | $132.5M | 2014 |
David Pfeiffer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Pfeiffer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Somu Subramaniam | 1 | 17 |
| Stephen Tullman | 1 | 7 |
| Somasundaram Subramaniam | 1 | 5 |
| Neal Walker | 1 | 5 |
| Douglas Gessl | 1 | 4 |
| Jason Hong | 1 | 4 |
| Raju Mohan | 1 | 4 |
| Kamil Ali-Jackson | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.